Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Is APBI appropriate for patients with rare tumor histology (mucinous, medullary, or tubular) if they meet all other suitability criteria?
Answer from: Radiation Oncologist at Community Practice
If phenotype right then it is tubular and mutinous are ER positive low grade tumor and are good candidates for APBI.
Comments
Radiation Oncologist at Cleveland Clinic
Agreed, these patients are good candidates for APB...
Radiation Oncologist at Mallory Radiotherapy, PLLC
Hi, thanks for your replies! I asked this question...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Medullary is Associated with BRCA 1 mutation and c...
2481
2482
2483
Sign in or Register to read more
7005
Related Questions
Do you offer APBI to patients with close margins?
Do you start systemic therapy for patients with previously localized HR+ breast cancer developing solitary bone metastasis which is now triple negative if there are no other sites of disease after metastasis-directed radiation?
Would you offer partial breast radiation for bilateral DCIS?
Do young, early-stage breast cancer patients with pCR to chemoimmunotherapy still benefit from PMRT?
Do you test /back project various bolus such as mesh or superflab to verify dosimetry and which do you prefer? How do you have staff apply it consistently? eg mesh bolus for chest wall
Would you start any treatment for radiation pneumonitis if there is a large area of consolidation in the irradiated lung field but the patient is asymptomatic?
How would you treat a patient with HER2 positive CNS only progression on fam-trastuzumab which had previously progressed on tucatinib/capecitabine/trastuzumab, and has failed both SRS and WBRT?
Would you omit post-lumpectomy radiotherapy for high clinical risk, but low molecular risk DCIS?
Are you comfortable combining palliative radiotherapy with capivasertib/fulvestrant?
Do you consider chest wall constraints when treating with 5-fraction APBI?
Agreed, these patients are good candidates for APB...
Hi, thanks for your replies! I asked this question...
Medullary is Associated with BRCA 1 mutation and c...